Pharmaceutical Technology on MSN
Aktis Oncology kicks 2026 IPO cycle off with $210m target
According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...
A potential initial public offering (IPO) next year by cryptocurrency exchange Kraken may attract fresh capital from traditional finance (TradFi) investors. Bitcoin recorded an all-time high price ...
Nexchain, and Bitcoin Hyper in this top crypto presale comparison. See which AI and blockchain presale looks strongest as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results